- Home
- CARM vs OMIC Comparison
CARM vs OMIC Comparison
Compare CARM & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- OMIC
- Stock Information
- Founded
- CARM 2016
- OMIC 2016
- Country
- CARM United States
- OMIC United States
- Employees
- CARM N/A
- OMIC N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- OMIC Medical/Dental Instruments
- Sector
- CARM Health Care
- OMIC Health Care
- Exchange
- CARM Nasdaq
- OMIC Nasdaq
- Market Cap
- CARM 41.5M
- OMIC 34.9M
- IPO Year
- CARM N/A
- OMIC 2021
- Fundamental
- Price
- CARM $0.94
- OMIC $22.73
- Analyst Decision
- CARM Strong Buy
- OMIC Hold
- Analyst Count
- CARM 3
- OMIC 2
- Target Price
- CARM $12.67
- OMIC $10.75
- AVG Volume (30 Days)
- CARM 183.3K
- OMIC 35.1K
- Earning Date
- CARM 11-07-2024
- OMIC 11-12-2024
- Dividend Yield
- CARM N/A
- OMIC N/A
- EPS Growth
- CARM N/A
- OMIC N/A
- EPS
- CARM N/A
- OMIC N/A
- Revenue
- CARM $20,268,000.00
- OMIC $2,667,000.00
- Revenue This Year
- CARM $50.40
- OMIC $10.41
- Revenue Next Year
- CARM N/A
- OMIC $222.15
- P/E Ratio
- CARM N/A
- OMIC N/A
- Revenue Growth
- CARM 41.13
- OMIC 2.77
- 52 Week Low
- CARM $0.80
- OMIC $5.34
- 52 Week High
- CARM $3.16
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- CARM 40.39
- OMIC 72.38
- Support Level
- CARM $0.96
- OMIC $21.56
- Resistance Level
- CARM $1.01
- OMIC $23.00
- Average True Range (ATR)
- CARM 0.06
- OMIC 1.19
- MACD
- CARM -0.01
- OMIC 0.64
- Stochastic Oscillator
- CARM 4.74
- OMIC 92.01
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.